---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-25-000196"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:54:02.243575+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Clover Health Q2 revenue $478M (+34% YoY), membership up 32%, GAAP net loss $11M

## Summary
- Q2 2025 total revenues $477.6M, up 34% YoY; insurance revenue $469.8M (+34.3%).
- Medicare Advantage membership 106,323 (+32% YoY); avg membership 105,494 (+31.8%).
- GAAP net loss from cont ops $10.6M; Adjusted net income $16.7M; Adjusted EBITDA $17.1M.
- FY2025 guidance: membership raised to 104K-108K; Adj SG&A improved to $335M-$345M; Insurance BER guided to 88.5%-89.5% (from 87%-88%).
- CEO highlights AI-driven clinical recommendations; published COPD whitepaper showing 15% fewer hospitalizations.

## SEC filing metadata
- accession: 0001801170-25-000196
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/0001801170-25-000196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/clov-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-25-000196
- JSON: https://secwatch.observer/filing/0001801170-25-000196.json
- Plain text: https://secwatch.observer/filing/0001801170-25-000196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.